Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Sir Marc Feldman Ph.D. | Co-Founder | 232.97k | -- | 1945 |
| Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder & Director | 168.75k | -- | 1948 |
| Mr. Lloyd Blair Jordan L.L.B., M.B.A. | CEO & Director | -- | -- | 1970 |
| Prof. Jagdeep Nanchahal M.D., Ph.D. | Co-Founder & Chairman of Clinical Advisory Board | -- | -- | -- |
| Mr. Eric R. Van Lent | CAO, Principal Accounting & Financial Officer | -- | -- | -- |
180 Life Sciences Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available